Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-10

Clinical Trial Update: IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism

View source ↗

Summary

A completed trial indicates that metomidate PET-CT more accurately predicts outcomes after adrenalectomy than adrenal venous sampling in patients with primary h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metomidate (metomidate)

Snippet

Sponsor: Queen Mary University of London | Conditions: Primary Aldosteronism, Hyperaldosteronism | Status: COMPLETED